157 related articles for article (PubMed ID: 17900371)
21. Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.
Covert D; Robin AL
Curr Med Res Opin; 2006 May; 22(5):971-6. PubMed ID: 16709319
[TBL] [Abstract][Full Text] [Related]
22. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials.
Li N; Chen XM; Zhou Y; Wei ML; Yao X
Clin Exp Ophthalmol; 2006 Nov; 34(8):755-64. PubMed ID: 17073898
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of intraocular pressure reducing effects of three prostaglandin eyedrops in open-angle glaucoma].
Huang HL; Sun XH; Xiao M
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):109-13. PubMed ID: 21426839
[TBL] [Abstract][Full Text] [Related]
24. [Cost-efficacy analysis of fixed combinations of prostaglandin/prostamide for treating glaucoma].
Martínez A; Slof J
Arch Soc Esp Oftalmol; 2008 Oct; 83(10):595-600. PubMed ID: 18855279
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.
Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
Clin Exp Ophthalmol; 2010 Oct; 38(7):678-82. PubMed ID: 20456437
[TBL] [Abstract][Full Text] [Related]
26. A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension.
Walt JG; Lee JT
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S36-44. PubMed ID: 15016560
[TBL] [Abstract][Full Text] [Related]
27. Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
Noecker RS; Dirks MS; Choplin N;
Am J Ophthalmol; 2004 Jan; 137(1):210-1; author reply 211-2. PubMed ID: 14700685
[No Abstract] [Full Text] [Related]
28. Prostaglandin analog treatment of glaucoma and ocular hypertension.
Alexander CL; Miller SJ; Abel SR
Ann Pharmacother; 2002 Mar; 36(3):504-11. PubMed ID: 11895065
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France.
Payet S; Denis P; Berdeaux G; Launois R
Clin Drug Investig; 2008; 28(3):183-98. PubMed ID: 18266403
[TBL] [Abstract][Full Text] [Related]
30. Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches.
Orme M; Collins S; Loftus J
J Glaucoma; 2012 Sep; 21(7):433-49. PubMed ID: 21677590
[TBL] [Abstract][Full Text] [Related]
31. A cost-effectiveness comparison of bimatoprost versus latanoprost in patients with glaucoma or ocular hypertension.
Schwartz GF; Reardon G
Surv Ophthalmol; 2004; 49(6):621-3; author reply 623-4. PubMed ID: 15530957
[No Abstract] [Full Text] [Related]
32. 24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension.
Hepsen IF; Ozkaya E
Eye (Lond); 2007 Apr; 21(4):453-8. PubMed ID: 16543930
[TBL] [Abstract][Full Text] [Related]
33. Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension.
Plosker GL; Keam SJ
Pharmacoeconomics; 2006; 24(3):297-314. PubMed ID: 16519552
[TBL] [Abstract][Full Text] [Related]
34. Update on prostaglandin analogs.
Hylton C; Robin AL
Curr Opin Ophthalmol; 2003 Apr; 14(2):65-9. PubMed ID: 12698043
[TBL] [Abstract][Full Text] [Related]
35. First-year treatment patterns among new initiators of topical prostaglandin analogs.
Schmier JK; Covert DW; Robin AL
Curr Med Res Opin; 2009 Apr; 25(4):851-8. PubMed ID: 19231912
[TBL] [Abstract][Full Text] [Related]
36. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.
Varma R; Hwang LJ; Grunden JW; Bean GW
Am J Ophthalmol; 2008 Feb; 145(2):336-42. PubMed ID: 18222194
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
[TBL] [Abstract][Full Text] [Related]
38. Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.
Honrubia F; García-Sánchez J; Polo V; de la Casa JM; Soto J
Br J Ophthalmol; 2009 Mar; 93(3):316-21. PubMed ID: 19019922
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
Aptel F; Cucherat M; Denis P
J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
[TBL] [Abstract][Full Text] [Related]
40. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study.
Bernstein P
Am J Ophthalmol; 2004 Feb; 137(2):387-8; author reply 388-9. PubMed ID: 14962451
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
